Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990
In Brief: Paul Sugarbaker to Head New DC Cancer Center; Michael Shimkin Dies; Tel Aviv Conference “Safe”
Broder Sworn In, Cites Three ‘Teachers’ – Gallo, Waldermann, DeVita
New Food Technology Could Lower Cancer Risk, Greenwald Says; Nutrition Lab Needed
Sullivan Confirmation Hearing Set For Feb. 1
USC Cancer Center Plans Expansion, Gets New Name
AACR Receives Record Number of Abstracts
Trending Stories
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology
My mother instilled in me: “Never become a product of your circumstances.” - What happened at FDA? Replimune approval raises questions
- What are The CheckPoints movin’ and groovin’ to this summer?
Join the journal club with the best bops: We asked SITC’s 13-piece band of medical musicians for the top papers and songs of the summer - Senate passes stopgap bill that would ban OMB from finalizing rule that would politicize science









